SAM Advisors LLC Has $1.22 Million Position in Kenvue Inc. $KVUE

SAM Advisors LLC grew its stake in Kenvue Inc. (NYSE:KVUE) by 3.1% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 58,192 shares of the company’s stock after purchasing an additional 1,724 shares during the period. Kenvue comprises approximately 0.4% of SAM Advisors LLC’s investment portfolio, making the stock its 23rd largest position. SAM Advisors LLC’s holdings in Kenvue were worth $1,218,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in KVUE. Pittenger & Anderson Inc. acquired a new stake in shares of Kenvue in the 1st quarter valued at approximately $30,000. Trust Co. of Vermont boosted its stake in shares of Kenvue by 266.8% in the 2nd quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock valued at $33,000 after purchasing an additional 1,150 shares in the last quarter. TruNorth Capital Management LLC acquired a new stake in shares of Kenvue in the 1st quarter valued at approximately $36,000. Truvestments Capital LLC acquired a new stake in shares of Kenvue in the 1st quarter valued at approximately $37,000. Finally, Clal Insurance Enterprises Holdings Ltd boosted its stake in shares of Kenvue by 378.5% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company’s stock valued at $39,000 after purchasing an additional 1,287 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on KVUE shares. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a research note on Tuesday, October 14th. JPMorgan Chase & Co. cut their target price on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a research report on Friday, October 10th. UBS Group cut their target price on shares of Kenvue from $23.00 to $17.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. Redburn Partners set a $22.00 target price on shares of Kenvue in a research report on Friday, September 26th. Finally, Bank of America cut their target price on shares of Kenvue from $25.00 to $21.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Kenvue has an average rating of “Hold” and a consensus target price of $21.18.

Kenvue Stock Up 8.4%

Shares of NYSE KVUE opened at $15.30 on Friday. The company has a market capitalization of $29.37 billion, a P/E ratio of 20.68, a price-to-earnings-growth ratio of 2.20 and a beta of 0.72. Kenvue Inc. has a 52-week low of $14.05 and a 52-week high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98. The company’s 50 day moving average price is $18.54 and its 200-day moving average price is $21.04.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.01. The firm had revenue of $3.84 billion for the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The company’s revenue for the quarter was down 4.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were given a $0.2075 dividend. This is an increase from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date was Wednesday, August 13th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 5.4%. Kenvue’s dividend payout ratio is presently 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.